[Federal Register Volume 84, Number 36 (Friday, February 22, 2019)]
[Notices]
[Pages 5685-5686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03101]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-0978]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Emerging Infections Program to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on November 15, 2018 to obtain comments from
the public and affected agencies. CDC did not receive comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Emerging Infections Program (OMB Control No. 0920-0978, Expiration
Date 5/31/2021)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases.
Activities of the EIPs fall into the following general categories:
(1) Active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies. Activities of the EIPs are designed to: (1) Address
issues that the EIP network is particularly suited to investigate; (2)
maintain sufficient flexibility for emergency response and new problems
as they arise; (3) develop and evaluate public health interventions to
inform public health policy and treatment guidelines; (4) incorporate
training as a key function; and (5) prioritize projects that lead
directly to the prevention of disease.
A revision is being submitted to make existing collection
instruments clearer and to add several new forms specifically surveying
laboratory practices. These forms will allow the EIP to better detect,
identify, track changes in laboratory testing methodology, gather
information about laboratory utilization in the EIP catchment area to
ensure that all cases are being captured, and survey EIP staff to
evaluate program quality.
The total estimated burden is 40,601 hours per year, an increase of
612 hours. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
responders respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department............... ABCs Case Report Form... 10 809 20/60
ABCs Invasive 10 22 10/60
Pneumococcal Disease in
Children Case Report
Form.
ABCs H. influenzae 10 6 10/60
Neonatal Sepsis
Expanded Surveillance
Form.
ABCs Severe GAS 10 136 20/60
Infection Supplemental
Form.
ABCs Neonatal Infection 10 37 20/60
Expanded Tracking Form.
FoodNet Campylobacter... 10 942 21/60
FoodNet Cyclospora...... 10 163 10/60
FoodNet Listeria 10 15 20/60
monocytogenes.
FoodNet Salmonella...... 10 789 21/60
[[Page 5686]]
FoodNet Shiga toxin 10 205 20/60
producing E. coli.
FoodNet Shigella........ 10 213 10/60
FoodNet Vibrio.......... 10 34 10/60
FoodNet Yersinia........ 10 48 10/60
FoodNet Hemolytic Uremic 10 10 1
Syndrome Case Report
Form.
FoodNet Clinical 10 70 20/60
Laboratory Practices
and Testing Volume--NEW.
Influenza 10 1000 25/60
Hospitalization
Surveillance Network
Case Report Form.
Influenza 10 333 5/60
Hospitalization
Surveillance Project
Vaccination Phone
Script Consent Form
(English/Spanish).
Influenza 10 333 5/60
Hospitalization
Surveillance Project
Vaccination Phone
Script (English/
Spanish).
Influenza 10 333 5/60
Hospitalization
Surveillance Project
Provider Vaccination
History Fax Form
(Children/Adults).
FluSurv-NET Laboratory 10 23 10/60
Survey--NEW.
HAIC CDI Case Report 10 1650 35/60
Form.
HAIC CDI Annual 10 16 10/60
Laboratory Survey--NEW.
HAIC CDI Annual 10 1 15/60
Surveillance Officers
Survey--NEW.
HAIC CDI LTCF Survey-- 10 45 5/60
NEW.
HAIC Multi-site Gram- 10 500 25/60
Negative Bacilli Case
Report Form (MuGSI-CRE/
CRAB).
HAIC Multi-site Gram- 10 1200 25/60
Negative Surveillance
Initiative--Extended-
Spectrum Beta-Lactamase-
Producing
Enterobacteriaceae
(MuGSI-ESBL).
HAIC Invasive 10 474 25/60
Methicillin-resistant
Staphylococcus aureus
(MRSA).
HAIC Invasive 10 754 25/60
Methicillin-sensitive
Staphylococcus aureus
(MSSA).
HAIC Invasive 10 11 8/60
Staphylococcus aureus
Annual Laboratory
Survey--NEW.
HAIC Invasive 10 1 10/60
Staphylococcus aureus
Annual Surveillance
Officers Survey--NEW.
HAIC Candidemia Case 9 800 20/60
Report Form.
HAIC Candidemia Periodic 9 15 20/60
Laboratory Survey--NEW.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-03101 Filed 2-21-19; 8:45 am]
BILLING CODE 4163-18-P